# Robert G. Hart

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-g-hart/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,633 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 93 |
| i10-index | 229 |
| Last Known Institution | University of British Columbia |
| OpenAlex ID | https://openalex.org/A5086609118 |
| ORCID iD | https://orcid.org/0000-0002-3210-167X |
| Works | 362 |

## Researcher papers

- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source](https://scholariq.org/papers/rivaroxaban-for-stroke-prevention-after-embolic-stroke-of-undetermined-source/)
- [Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-peripheral-or/)
- [Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin](https://scholariq.org/papers/safety-of-proton-pump-inhibitors-based-on-a-large-multi-year-randomized-trial-of/)
- [National Stroke Association guidelines for the management of transient ischemic attacks](https://scholariq.org/papers/national-stroke-association-guidelines-for-the-management-of-transient-ischemic/)
- [Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial](https://scholariq.org/papers/rivaroxaban-or-aspirin-for-patent-foramen-ovale-and-embolic-stroke-of/)
- [The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial](https://scholariq.org/papers/the-effect-of-dulaglutide-on-stroke-an-exploratory-analysis-of-the-rewind-trial/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)

## Researcher university

- [University of British Columbia](https://scholariq.org/institutions/university-of-british-columbia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.